Pharmacological Therapy Determines the Gut Microbiota Modulation by a Pomegranate Extract Nutraceutical in Metabolic Syndrome: A Randomized Clinical Trial
ConclusionThe prebiotic effect of PE depended on the medication, mainly on HP ‐treatments. Targeting GM could complement MetS therapy, but the patients’ drug therapy should be considered individually.This article is protected by copyright. All rights reserved
Source: Molecular Nutrition and Food Research - Category: Food Science Authors: Adri án Cortés‐Martín,
Carlos Eduardo Iglesias‐Aguirre,
Amparo Meoro,
María Victoria Selma,
Juan Carlos Espín Tags: Research Article Source Type: research
More News: Cardiology | Clinical Trials | Diabetes | Endocrinology | Food Science | Heart | Metabolic Syndrome | Nutrition | Pomegranates